XML 45 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
BENEFICIARIES' EQUITY OF THE PARENT COMPANY
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
BENEFICIARIES' EQUITY OF THE PARENT COMPANY
11. BENEFICIARIES’ EQUITY OF THE PARENT COMPANY
Earnings per Share (EPS)
The following table details the number of shares and net income used to calculate basic and diluted earnings per share (in thousands, except share and per share amounts; results may not add due to rounding):
Three Months Ended March 31,
20242023
BasicDilutedBasicDiluted
Numerator
Net loss$(16,414)$(16,414)$(5,276)$(5,276)
Net loss attributable to noncontrolling interests46 46 17 17 
Nonforfeitable dividends allocated to unvested restricted shareholders(336)(336)(70)(70)
Net loss attributable to common shareholders$(16,704)$(16,704)$(5,329)$(5,329)
Denominator
Weighted-average shares outstanding172,207,037 172,207,037 171,673,167 171,673,167 
Loss per Common Share:
Net loss attributable to common shareholders$(0.10)$(0.10)$(0.03)$(0.03)
Redeemable common limited partnership units totaling 515,595 and 516,467 at March 31, 2024 and March 31, 2023, respectively, were excluded from the diluted earnings per share computations because they are not dilutive.
Unvested restricted shares are considered participating securities which require the use of the two-class method for the computation of basic and diluted earnings per share. For the three months ended March 31, 2024 and 2023, earnings representing nonforfeitable dividends as noted in the table above were allocated to the unvested restricted shares issued to the Company’s executives and other employees under the Company’s shareholder-approved long-term equity incentive plan.
Common Shares
On February 14, 2024, the Parent Company declared a distribution of $0.15 per common share, totaling $26.3 million, which was paid on April 18, 2024 to shareholders of record as of April 4, 2024.
The Parent Company maintains a common share repurchase program under which the Board of Trustees has authorized the Parent Company to repurchase its common shares. On January 3, 2019, the Board of Trustees authorized the repurchase of up to $150.0 million of the Company's common shares from and after January 3, 2019. During the three months ended March 31, 2024 and March 31, 2023, the Company did not repurchase any common shares.